Aurigene Oncology Profile
Key Indicators
- Authorised Capital ₹ 240.00 Cr
- Paid Up Capital ₹ 187.56 Cr
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.59 Cr
- Revenue Growth -4.29%
- Profit Growth -44.97%
- Ebitda -46.97%
- Net Worth -42.51%
- Total Assets -37.46%
About Aurigene Oncology
Aurigene Oncology Limited (AOL) is a leading Public Limited Indian Non-Government Company incorporated in India on 10 August 2001 and has a history of 23 years and eight months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Aurigene Discovery Technologies P Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 240.00 Cr and a paid-up capital of Rs 187.56 Cr.
The company has closed loans amounting to ₹6.59 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aurigene Oncology Limited India are Varun Challapalli as Company Secretary, Brijesh Karnani as Cfo, and Muralidhara Ramachandra as Ceo. Venkateswara Gunupati, Satish Kallam, Bruce Carter, and Four other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239KA2001PLC029391
- Company No.
029391
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2001
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Life Sciences
Pharma
What products or services does Aurigene Oncology Limited offer?
Aurigene Oncology Limited offers a wide range of products and services, including Project Feasibility Studies, Market Research Service, Licensing Services, Import Licensing Services, Pharmaceutical Services, Biotechnology Services, Fertilizer, Amino Acids, DGFT Licensing, Welfare Organization Services.
Aurigene Oncology Limited
Explore comprehensive data for Aurigene Oncology Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Aurigene Oncology?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varun Challapalli | Company Secretary | 20-Feb-2024 | Current |
| Brijesh Karnani | CFO | 26-Mar-2020 | Current |
Muralidhara Ramachandra  | CEO | 01-Jul-2019 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satish Kallam | Director | 10-Aug-2001 | Current |
| Venkateswara Gunupati | Director | 10-Aug-2001 | Current |
Bruce Carter  | Director | 30-Mar-2015 | Current |
| Venkata Motupalli | Director | 19-Oct-2023 | Current |
| Shubhada Chiplunkar | Director | 01-Oct-2022 | Current |
| Kumar Srinivasan | Director | 01-Oct-2022 | Current |
Financial Performance of Aurigene Oncology.
Aurigene Oncology Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.29% decrease. The company also saw a substantial fall in profitability, with a 44.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurigene Oncology?
In 2023, Aurigene Oncology had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr.Reddy's Institute Of Life SciencesVenkateswara Gunupati and Satish Kallam are mutual person
Greenpark Hotels And Resorts LimitedVenkateswara Gunupati and Satish Kallam are mutual person
Araku Originals Private LimitedSatish Kallam is a mutual person
Symbiotec Zenfold Private LimitedBuggana Hariharnath is a mutual person
- Symbiotec Pharmalab Private Limited
Buggana Hariharnath is a mutual person
Indian School Of BusinessVenkateswara Gunupati is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹6.59 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 6.50 Cr
- Icici Bank Limited : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Sep 2011 | State Bank Of India | ₹6.50 Cr | Satisfied |
| 21 Oct 2005 | Icici Bank Limited | ₹0.88 M | Satisfied |
How Many Employees Work at Aurigene Oncology?
Aurigene Oncology has a workforce of 479 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurigene Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurigene Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aurigene Oncology
Recent activity within the organization
- Annual General Meeting
Aurigene Oncology Limited last Annual general meeting of members was held on 26 Jul 2024 as per latest MCA records.
- Balance Sheet
Aurigene Oncology Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Director Appointment
Varun Kumar Challapalli was appointed as a Company Secretary was appointed as a Company Secretary on 20 Feb 2024 & has been associated with this company since 1 year 1 month .
- Director Appointment
Venkata Ramana Motupalli was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 1 year 5 months .
- Director Appointment
Shubhada Vivek Chiplunkar was appointed as a Director was appointed as a Director on 01 Oct 2022 & has been associated with this company since 2 years 6 months .
- Director Appointment
Kumar Srinivasan was appointed as a Director was appointed as a Director on 01 Oct 2022 & has been associated with this company since 2 years 6 months .
Recent News, Updates & Announcement
- Anticipation Builds for Phase 1 Study Results in December 2018 #PatienceIsAVirtue.
Me: Can't wait for the study results! Also me: But it's not until December 2018. #PatienceIsAVirtue #Phase1Data #StudyResults #December2018.
Frequently asked questions
What is the Incorporation or founding date of Aurigene Oncology Limited?
Aurigene Oncology Limited was incorporated on 10 Aug 2001.
What is authorized share capital and paid-up capital of Aurigene Oncology Limited?
The authorized share capital of Aurigene Oncology Limited is ₹ 240.00 Cr and paid-up capital is ₹ 187.56 Cr.
Who are the current board members & directors of Aurigene Oncology Limited?
Currently 10 directors are associated with Aurigene Oncology Limited.
- Varun Kumar Challapalli
- Venkateswara Prasad Gunupati
- Satish Reddy Kallam
- Bruce Leonard Andrews Carter
- Venkata Ramana Motupalli
- Shubhada Vivek Chiplunkar
- Brijesh Kumar Karnani
- Muralidhara Ramachandra
- Kumar Srinivasan
- Buggana Hariharnath
What is the registered address of Aurigene Oncology Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aurigene Oncology Limited is 39/49(P)Kiadb Industrial Area Electronics City Phase Ii India, Bangalore, Karnataka, 560100.
What is the corporate identification number (CIN) and company number of Aurigene Oncology Limited?
The corporate identification number (CIN) of Aurigene Oncology Limited is U24239KA2001PLC029391 and the company number is 029391 as per Ministry of Corporate Affairs (MCA).
What is the official website of Aurigene Oncology Limited?
The Official website of Aurigene Oncology Limited is https://www.aurigene.com
What has been the recent revenue trend for Aurigene Oncology Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Aurigene Oncology Limited has fallen by -4.29%.
How many employees does Aurigene Oncology Limited currently have?
As Per 2022 financial reports, 479 employees are currently employed by Aurigene Oncology Limited.
What change has been observed in the net worth of Aurigene Oncology Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Aurigene Oncology Limited has experienced an downturn of -42.51%.
When was the last Balance Sheet of Aurigene Oncology Limited filed with the ROC?
The most recent Balance Sheet for Aurigene Oncology Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Umang VohraDirector
Saumen ChakrabortyDirector
Julius KnowlesDirectorSV
Subramanian VasudevanDirectorSC
Satyanarayana ChavaliWholetime DirectorVA
Venkateswarlu AkellaDirectorPB
Poh BillDirectorJH
John HansenDirector
Similar Companies Based on Pharma Contract R&D
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India